Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine infusion and postoperative delirium in elderly hip fracture surgery
ChiCTR2400081681Phase 4Recruiting
- Sponsor
- Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative delirium (POD) (2 arms), sponsored by Chengdu Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Incidence of delirium within the first 3 postoperative days. Started Mar 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400081681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081681.